Phone: 1-800-958-1252
Fax: 1-800-673-9238
Online Prescriptions from PetDrugs.com
Free Shipping Now Available Worldwide Products for Dogs
Etogesic
Tell a Friend Click to tell a friend about
Etogesic

Etogesic

(Manufactured by: Boehringer Ingelheim)

Dose: 150mg
Quantity: 1 tablets
Price: $1.04 USD
Qty:

Description of Etogesic

Uses

Etogesic (etodolac) is an anti-inflammatory medication for dogs. Etogesic achieves peak plasma concentrations faster, and provides pain relief in a convenient, once-a-day dose.

 

Dosage and Administration

Always provide Client Information sheet with prescription. Carefully consider the potential benefits and risks of ETOGESIC and other treatment options before deciding to use ETOGESIC. Use the lowest effective dose for the shortest duration consistent with individual treatment response.

The recommended dose of ETOGESIC Tablets is 4.5 to 6.8 mg/lb body weight (10 to 15 mg/kg) administered once daily. Due to tablet sizes and scoring, dogs weighing less than 11 lb (5 kg) cannot be accurately dosed. The effective dose and duration should be based on clinical judgment of disease condition and patient tolerance of drug treatment. The initial dose level should be adjusted until a satisfactory clinical response is obtained, but should not exceed 15 mg/kg once daily.

 

Contra-indications

EtoGesic Tablets are contraindicated in animals previously found to be hypersensitive to etodolac.

WARNINGS: Not for human use. Keep out of reach of children. Consult a physician in cases of accidental ingestion by humans. Do not use in cats. For use in dogs only.

Pharmaceutical Precautions

The safe use of ETOGESIC Tablets in dogs less than 12 months of age, pregnant, breeding or lactating dogs has not been established. Owners should be advised to observe for signs of potential drug reactions. If additional pain medication is warranted after administration of the daily dose of ETOGESIC, alternative analgesia should be considered. The use of another NSAID is not recommended.

As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal, and hepatic toxicity. Sensitivity to drug-associated adverse effects varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from other NSAIDs. Dogs at greatest risk for adverse events are those that are dehydrated, on concomitant diuretic therapy, or those with renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached and monitored. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to induce gastrointestinal ulceration and/or gastrointestinal perforation, concomitant use of ETOGESIC with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided.

The use of concomitantly protein-bound drugs with ETOGESIC has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant and behavioral medications. The influence of concomitant drugs that may inhibit metabolism of ETOGESIC has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use.

Treatment with ETOGESIC Tablets should be terminated if signs such as inappetence, emesis, fecal abnormalities, or anemia are observed. Dogs treated with non-steroidal anti-inflammatory drugs on a continuing basis, including etodolac, should be evaluated periodically to ensure that the drug is still necessary and well tolerated.

ETOGESIC Tablets, as with other non-steroidal anti-inflammatory drugs, may exacerbate clinical signs in dogs with pre-existing or occult gastrointestinal, hepatic or cardiovascular abnormalities, blood dyscrasias, or bleeding disorders.

Store at controlled room temperature, 15-30°C (59-86°F).

PLEASE NOTE: Etogesic is only available by prescription and REQUIRES A VALID PRESCRIPTION be mailed, faxed or emailed to PetDrugs.com to complete your order.

View Category

* All final sales are billed in $ USD. All prices are subject to change at any time. For questions regarding pricing and availability of products from PetDrugs.com you may call 1-800-958-1252.

"Pet Drugs" and "PetDrugs.com" are registered trademarks used under exclusive license by CanadaDrugs.com Customer Care. All rights reserved.

Canadian Prescription Medications dispensed by CanadaDrugs.com (Manitoba Pharmaceutical Association License Number 32195). Credit Cards will be billed by "CanadaDrugs.com"

Copyright © 2010 PetDrugs.com, all rights reserved.

About PetDrugs.com | Site Map | Contact Us

Mailing Address:
PetDrugs.com
24 Terracon Place
Winnipeg, Manitoba, Canada
R2J 4G7

Please report spam and other email abuse to: abuse@petdrugs.com